Endometrial blood flow improvement

Endometrial blood flow improvement is a physiological process and therapeutic objective rather than a specific molecular target like a receptor or enzyme. It refers to the enhancement of blood supply to the uterine lining, which is a critical determinant of endometrial receptivity and successful embryo implantation (Sher & Fisch, 2000, Fertility and Sterility). Adequate perfusion ensures the delivery of oxygen, nutrients, and signaling molecules necessary for the decidualization of the stroma and the development of a receptive environment for a blastocyst. Clinically, impaired blood flow is often characterized by high resistance in the uterine arteries and is a common factor in patients with a thin endometrium or recurrent implantation failure (Takasaki et al., 2010, Fertility and Sterility). Pharmacological interventions to improve endometrial blood flow typically target the vascular smooth muscle or blood rheology. For example, Sildenafil citrate is used off-label to enhance the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway, leading to vasodilation of the uterine spiral arteries. Similarly, low-dose aspirin is employed to prevent micro-clots that might impede perfusion, while L-arginine serves as a substrate for nitric oxide synthesis (Hsu et al., 2015, Cochrane Database of Systematic Reviews). Monitoring of this process is primarily conducted via Doppler ultrasound, measuring indices such as the pulsatility index (PI) and resistance index (RI) to assess the efficacy of treatment in improving uterine hemodynamics.

Other names

Uterine blood flow enhancementEndometrial perfusionUterine artery hemodynamicsEndometrial receptivity improvement

Improvement is achieved through various pharmacological mechanisms including the inhibition of phosphodiesterase type 5 (PDE5) to increase cGMP-mediated vasodilation, the provision of nitric oxide precursors (L-arginine), the reduction of platelet aggregation and microthrombosis (low-dose aspirin), and the reduction of blood viscosity or oxidative stress (Pentoxifylline and Vitamin E).